What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- Cytokine
His scientific interests lie mostly in Immunology, Molecular biology, Cytotoxic T cell, Cytokine and CD8.
His Immunology study combines topics from a wide range of disciplines, such as Cancer research and Myofibroblast.
His Molecular biology research is multidisciplinary, incorporating perspectives in Apoptosis, Ex vivo and Jurkat cells.
His Cytotoxic T cell research is multidisciplinary, relying on both T cell and T lymphocyte.
Peter D. Katsikis has researched T cell in several fields, including Fas receptor and Cell biology.
His research in Cytokine intersects with topics in Tumor necrosis factor alpha and Synovial membrane.
His most cited work include:
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha (1003 citations)
- In vivo detection and imaging of phosphatidylserine expression during programmed cell death (540 citations)
- Immunoregulatory role of interleukin 10 in rheumatoid arthritis. (468 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Immunology, Cytotoxic T cell, CD8, T cell and Virology.
His study in Cytokine, Immune system, Rheumatoid arthritis, Inflammation and Tumor necrosis factor alpha falls under the purview of Immunology.
His work deals with themes such as Cancer research and Cell biology, which intersect with Cytotoxic T cell.
He combines subjects such as Molecular biology, T-cell receptor and Fas receptor with his study of CD8.
His Molecular biology study which covers Programmed cell death that intersects with Annexin and In vivo.
His Interleukin 21 research includes elements of CD40 and Antigen-presenting cell.
He most often published in these fields:
- Immunology (52.23%)
- Cytotoxic T cell (35.03%)
- CD8 (29.30%)
What were the highlights of his more recent work (between 2017-2021)?
- Cell biology (18.47%)
- Immune system (16.56%)
- Immunology (52.23%)
In recent papers he was focusing on the following fields of study:
Peter D. Katsikis mainly focuses on Cell biology, Immune system, Immunology, Cytotoxic T cell and CD8.
In his work, Intracellular, Apoptosis, Programmed cell death, Cell culture and Downregulation and upregulation is strongly intertwined with RNA, which is a subfield of Cell biology.
The concepts of his Immunology study are interwoven with issues in Lung and Respiratory system.
His Cytotoxic T cell research incorporates themes from T cell, Regulation of gene expression, microRNA and Chronic infection.
His T cell study also includes fields such as
- Receptor expression which connect with Cytokine, P110δ and Cytotoxicity,
- Cancer research that intertwine with fields like Immunity and Tumor microenvironment.
His work carried out in the field of CD8 brings together such families of science as Transgene, Cell signaling and Cellular differentiation.
Between 2017 and 2021, his most popular works were:
- Convalescent Plasma for COVID-19. A randomized clinical trial (112 citations)
- Long-Term Persistence of Exhausted CD8 T Cells in Chronic Infection Is Regulated by MicroRNA-155. (35 citations)
- Transcriptome Analysis of Infected and Bystander Type 2 Alveolar Epithelial Cells during Influenza A Virus Infection Reveals In Vivo Wnt Pathway Downregulation. (25 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Cytokine
Peter D. Katsikis focuses on Cell biology, Stem cell, Influenza A virus, Virus and A549 cell.
His research integrates issues of microRNA, CD8, Lymphocytic choriomeningitis and Cellular differentiation in his study of Cell biology.
His study in Stem cell is interdisciplinary in nature, drawing from both Interferon, Transcriptome and Wnt signaling pathway.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
